Page 9 - Binder2
P. 9
Chapter 6: Pharma’s Worst Nightmare
• Why big pharma hasn’t embraced edible biologics.
• Regulatory friction: FDA hesitation, classification
limbo.
• IP disruption and manufacturing decentralization.
Chapter 7: Reinventing Drug Delivery
• Rethinking the role of doctors, clinics, and even
pharmacies.
• Plant based biological production in local
communities
• More ethical distribution of cutting-edge medicine
Chapter 8: From Resistance to Revolution
• The ecosystem of startups, universities, and
regulators trying to make it happen.
• What needs to change: policy, mindset, and
investment.
• Call to action for scientists, entrepreneurs, and
patients.
7
